Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Hair transplant destroyed by lichen planopilaris.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Future hair cosmetics will be safer and more effective.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Laser treatment increases hair density and thickness safely in women with hair loss.

Creating a natural-looking hairline in hair restoration surgery involves using follicular unit grafts, proper hair placement, and artistic skills to give the illusion of density.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

An improved scalp reduction technique reduces the need for hair grafts and has minimal complications.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Mini-micrografting in hair transplants can give similar density to older methods with fewer sessions.

Hair restoration surgery effectively treats hair loss with natural-looking results, using techniques like stem cells and platelet-rich plasma.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Successful hair transplant surgery depends on careful patient selection, proper surgical plan and technique, and attentive aftercare.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.